Flexion Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference
02 Giugno 2021 - 10:30PM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that
Michael Clayman, M.D., President and Chief Executive Officer, will
participate in an analyst-led fireside chat at the Goldman Sachs
42nd Annual Global Healthcare Virtual Conference. The virtual
fireside chat is scheduled to begin at 3:50 p.m. ET on
Tuesday, June 8, 2021.
To access the live webcast and subsequent archived recording of
the presentation, please visit the Flexion website
at http://ir.flexiontherapeutics.com.
About Flexion TherapeuticsFlexion Therapeutics
(Nasdaq:FLXN) is a biopharmaceutical company focused on the
development and commercialization of novel, local therapies for the
treatment of people with musculoskeletal conditions, beginning with
osteoarthritis, the most common form of arthritis. The Company's
core values are focus, ingenuity, tenacity, transparency and fun.
Please visit flexiontherapeutics.com.
Contact:
Scott YoungVice President, Corporate Communications &
Investor RelationsFlexion Therapeutics, Inc.T:
781-305-7194syoung@flexiontherapeutics.com
Grafico Azioni Flexion Therapeutics (NASDAQ:FLXN)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Flexion Therapeutics (NASDAQ:FLXN)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Flexion Therapeutics Inc (NASDAQ): 0 articoli recenti
Più Articoli Notizie